Drug Patents owned by Kythera Biopharms

1. Drug name - KYBELLA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8242294 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods
May, 2028

(5 years from now)

CN101711254A KYTHERA BIOPHARMS Synthetic Bile Acid Composition, Method, And Preparation
Oct, 2016

(5 years ago)

CN108191940B KYTHERA BIOPHARMS Synthetic Bile Acid Compositions, Methods And Formulations
Jun, 2028

(5 years from now)

CN106083969A KYTHERA BIOPHARMS Synthetic Bile Acid Composition, Method And Preparation
Jun, 2028

(5 years from now)

CN106083969B KYTHERA BIOPHARMS Synthetic Bile Acid Composition, Method And Preparation
Jun, 2028

(5 years from now)

CN108191940A KYTHERA BIOPHARMS Synthetic Bile Acid Composition, Method And Preparation
Jun, 2028

(5 years from now)

EP3002290A2 KYTHERA BIOPHARMS Synthesis Of Deoxycholic Acid (Dca)
Jun, 2028

(5 years from now)

EP2407475B1 KYTHERA BIOPHARMS Synthetic Bile Acid Preparation
Jun, 2028

(5 years from now)

EP3002290A3 KYTHERA BIOPHARMS Synthesis Of Deoxycholic Acid (Dca)
Jun, 2028

(5 years from now)

EP2407475A3 KYTHERA BIOPHARMS Synthetic Bile Acid Composition, Method, And Preparation
Jun, 2028

(5 years from now)

EP3002290B1 KYTHERA BIOPHARMS Synthesis Of Deoxycholic Acid (Dca)
Jun, 2028

(5 years from now)

EP2407475A2 KYTHERA BIOPHARMS Synthetic Bile Acid Preparation
Jun, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8846066 KYTHERA BIOPHARMS Methods and related compositions for reduction of fat and skin tightening Feb, 2025

(2 years from now)

US8298556 KYTHERA BIOPHARMS Methods and related compositions for the non-surgical removal of fat Aug, 2025

(2 years from now)

US7622130 KYTHERA BIOPHARMS Methods and compositions for the non-surgical removal of fat Dec, 2027

(5 years from now)

US7754230 KYTHERA BIOPHARMS Methods and related compositions for reduction of fat Dec, 2027

(5 years from now)

US8546367 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods Feb, 2028

(5 years from now)

US9949986 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods Feb, 2028

(5 years from now)

US9636349 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods Feb, 2028

(5 years from now)

US9522155 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods Feb, 2028

(5 years from now)

US8461140 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods Feb, 2028

(5 years from now)

US8883770 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods Feb, 2028

(5 years from now)

US8653058 KYTHERA BIOPHARMS Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits Mar, 2030

(7 years from now)

US8101593 KYTHERA BIOPHARMS Formulations of deoxycholic acid and salts thereof Mar, 2030

(7 years from now)

US8367649 KYTHERA BIOPHARMS Formulations of deoxycholic acid and salts thereof Mar, 2030

(7 years from now)

US10500214 KYTHERA BIOPHARMS Formulations of deoxycholic acid and salts thereof Mar, 2030

(7 years from now)

Drugs and Companies using DEOXYCHOLIC ACID ingredient

Treatment: Method for reduction of submental fat; Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults by means of reducing submental fat volume as described in the approved labeling

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
20MG/2ML (10MG/ML) SOLUTION;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.